DS.TO vs. BSX
DS.TO (Dividend Select 15 Corp.) and BSX (Boston Scientific Corporation) are both stocks. DS.TO operates in Asset Management (Financial Services), while BSX operates in Medical Devices (Healthcare). Over the past 10 years, DS.TO returned 10.10%/yr vs 8.91%/yr for BSX. At a 0.14 correlation, their price movements are largely independent.
Performance
DS.TO vs. BSX - Performance Comparison
Loading charts...
Different Trading Currencies
DS.TO is traded in CAD, while BSX is traded in USD. To make them comparable, the BSX values have been converted to CAD using the latest available exchange rates.
Returns By Period
In the year-to-date period, DS.TO achieves a 11.26% return, which is significantly higher than BSX's -48.28% return. Over the past 10 years, DS.TO has outperformed BSX with an annualized return of 10.10%, while BSX has yielded a comparatively lower 8.91% annualized return.
DS.TO
- 1D
- 0.00%
- 1M
- 4.23%
- YTD
- 11.26%
- 6M
- 12.63%
- 1Y
- 33.11%
- 3Y*
- 17.43%
- 5Y*
- 10.30%
- 10Y*
- 10.10%
BSX
- 1D
- -0.41%
- 1M
- -11.37%
- YTD
- -48.28%
- 6M
- -49.77%
- 1Y
- -51.87%
- 3Y*
- -0.12%
- 5Y*
- 5.93%
- 10Y*
- 8.91%
DS.TO vs. BSX - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
DS.TO Dividend Select 15 Corp. | 11.26% | 20.72% | 21.02% | -11.35% | -14.44% | 70.99% | -3.59% | 19.99% | -12.28% | 8.27% |
BSX Boston Scientific Corporation | -48.28% | 1.85% | 67.78% | 22.19% | 16.68% | 17.10% | -21.84% | 21.67% | 54.65% | 7.31% |
Correlation
The correlation between DS.TO and BSX is 0.07, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.07 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.09 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.11 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.15 |
Correlation (All Time) Calculated using the full available price history since Nov 19, 2010 | 0.14 |
Fundamentals
DS.TO:
CA$58.79M
BSX:
$72.58B
DS.TO:
1.29
BSX:
2.81
DS.TO:
CA$9.75M
BSX:
$20.62B
DS.TO:
CA$5.88M
BSX:
$14.52B
DS.TO:
CA$13.04M
BSX:
$4.76B
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
DS.TO vs. BSX — Risk / Return Rank
DS.TO
BSX
DS.TO vs. BSX - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Dividend Select 15 Corp. (DS.TO) and Boston Scientific Corporation (BSX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| DS.TO | BSX | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +3.54 | ||
| Sortino ratioReturn per unit of downside risk | +5.02 | ||
| Omega ratioGain probability vs. loss probability | 1.38 | 0.68 | +0.70 |
| Calmar ratioReturn relative to maximum drawdown | 4.90 | -0.93 | +5.83 |
| Martin ratioReturn relative to average drawdown | 17.60 | -2.05 | +19.65 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| DS.TO | BSX | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 2.06 | -1.48 | +3.54 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.67 | 0.24 | +0.44 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.52 | 0.34 | +0.18 |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.00 | 0.41 | -0.41 |
Drawdowns
DS.TO vs. BSX - Drawdown Comparison
The maximum DS.TO drawdown since its inception was -43.13%, smaller than the maximum BSX drawdown of -60.93%. Use the drawdown chart below to compare losses from any high point for DS.TO and BSX.
Loading charts...
Drawdown Indicators
| DS.TO | BSX | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -43.13% | -60.93% | +17.80% |
Max Drawdown (1Y)Largest decline over 1 year | -6.62% | -55.90% | +49.28% |
Max Drawdown (3Y)Largest decline over 3 years | -11.68% | -56.59% | +44.91% |
Max Drawdown (5Y)Largest decline over 5 years | -32.25% | -56.59% | +24.34% |
Max Drawdown (10Y)Largest decline over 10 years | -43.13% | -56.59% | +13.46% |
Current DrawdownCurrent decline from peak | -1.12% | -55.48% | +54.36% |
Average DrawdownAverage peak-to-trough decline | -8.36% | -16.21% | +7.85% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 1.84% | 25.26% | -23.42% |
Volatility
DS.TO vs. BSX - Volatility Comparison
The current volatility for Dividend Select 15 Corp. (DS.TO) is 5.83%, while Boston Scientific Corporation (BSX) has a volatility of 16.48%. This indicates that DS.TO experiences smaller price fluctuations and is considered to be less risky than BSX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| DS.TO | BSX | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 5.83% | 16.48% | -10.65% |
Volatility (6M)Calculated over the trailing 6-month period | 12.83% | 33.15% | -20.32% |
Volatility (1Y)Calculated over the trailing 1-year period | 15.78% | 35.14% | -19.36% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 15.36% | 24.89% | -9.53% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 19.42% | 26.19% | -6.77% |
Dividends
DS.TO vs. BSX - Dividend Comparison
DS.TO's dividend yield for the trailing twelve months is around 9.01%, while BSX has not paid dividends to shareholders.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
BSX Boston Scientific Corporation | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
DS.TO Dividend Select 15 Corp. | 9.01% | 9.15% | 9.35% | 10.99% | 11.09% | 8.07% | 9.98% | 9.81% | 12.03% | 10.13% | 9.19% | 12.15% |
Financials
DS.TO vs. BSX - Financials Comparison
This section allows you to compare key financial metrics between Dividend Select 15 Corp. and Boston Scientific Corporation. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
DS.TO vs. BSX - Profitability Comparison
DS.TO - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Dividend Select 15 Corp. reported a gross profit of 0.00 and revenue of 2.91M. Therefore, the gross margin over that period was 0.0%.
BSX - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Boston Scientific Corporation reported a gross profit of 3.61B and revenue of 5.20B. Therefore, the gross margin over that period was 69.4%.
DS.TO - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Dividend Select 15 Corp. reported an operating income of 915.84K and revenue of 2.91M, resulting in an operating margin of 31.5%.
BSX - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Boston Scientific Corporation reported an operating income of 1.07B and revenue of 5.20B, resulting in an operating margin of 20.6%.
DS.TO - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Dividend Select 15 Corp. reported a net income of 915.84K and revenue of 2.91M, resulting in a net margin of 31.5%.
BSX - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Boston Scientific Corporation reported a net income of 1.34B and revenue of 5.20B, resulting in a net margin of 25.7%.
Frequently Asked Questions
DS.TO and BSX have a correlation of 0.07, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
Find the right allocation for DS.TO and BSX
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer